Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01475045
NCT01475045
Completed
N/A

Multicenter, Prospective, Non Interventional Observational Study in Treatments of Asthma and Chronic Obstructive Pulmonary Disease (COPD)

Elpen Pharmaceutical Co. Inc.2 sites in 1 country1,160 target enrollmentJanuary 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAsthmaChronic Obstructive Pulmonary Disease

Overview

Phase
N/A
Intervention
Not specified
Conditions
Asthma
Sponsor
Elpen Pharmaceutical Co. Inc.
Enrollment
1160
Locations
2
Primary Endpoint
Patients' satisfaction
Status
Completed
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The aim of the study is to compare patients' satisfaction from the use of three different inhalation devices by using the FSI-10 questionnaire

Detailed Description

Patients are requested to reply to FSI-10 questionnaire regarding their satisfaction from inhalation devices. Patients are on 3 different asthma inhalation devices with combination treatment (Turbuhaler, Diskus, Elpenhaler)

Registry
clinicaltrials.gov
Start Date
January 2011
End Date
September 2011
Last Updated
14 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Patients \> 18 years old, both genders who are on their inhalation treatment at least two months before study enrollment,
  • •Who are able to be compliant to study procedures

Exclusion Criteria

  • •Patients \< 18 years old,
  • •Patients who are on their inhalation treatment less than two months before study enrollment
  • •Patients who are not able to be compliant to study procedures

Outcomes

Primary Outcomes

Patients' satisfaction

Time Frame: all study period (5 months)

Patients' replies to FSI-10 questionnaire valid in Greek language

Secondary Outcomes

  • Patients devices' use(all study period (5 months))

Study Sites (2)

Loading locations...

Similar Trials

Completed
N/A
Study to Evaluate Satisfaction and Usability of DuoResp® SPIROMAX® in Asthma and COPD TreatmentPatient Satisfaction
NCT02384577Teva Pharma GmbH4,034
Completed
Phase 4
Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD PatientsChronic Obstructive Pulmonary Disease (COPD)
NCT01727024Novartis Pharmaceuticals140
Completed
N/A
Re-usable Respimat® Soft MistTM Inhaler StudyPulmonary Disease, Chronic Obstructive
NCT04011735Boehringer Ingelheim262
Completed
N/A
Evaluating inhaler use technique and satisfaction with inhaler devices in Japanese patients with COPD
JPRN-UMIN000033527Juntendo University155
Terminated
Phase 4
A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic DrugSchizophrenia
NCT01592201Janssen Korea, Ltd., Korea13